• Table of Contents

  • Who Created Metildrostanolone and When?
  • The Creator of Metildrostanolone
  • The Rise and Fall of Metildrostanolone
  • Pharmacokinetic and Pharmacodynamic Properties
  • Expert Opinion
  • References

Who Created Metildrostanolone and When?

Metildrostanolone, also known as Superdrol, is a synthetic androgenic-anabolic steroid that has gained popularity in the bodybuilding and athletic communities due to its powerful effects on muscle growth and strength. But who exactly created this compound and when was it first introduced? In this article, we will delve into the history of metildrostanolone and its creator, as well as its pharmacokinetic and pharmacodynamic properties.

The Creator of Metildrostanolone

The credit for creating metildrostanolone goes to the pharmaceutical company Syntex Corporation, which was founded in 1944 by Russell Marker. Syntex Corporation was a pioneer in the development of synthetic hormones and steroids, and it was responsible for the creation of several other popular steroids such as Anadrol and Anavar.

In the late 1950s, Syntex Corporation began researching and developing a new synthetic steroid that would have similar effects to the popular steroid methandrostenolone (Dianabol), but with fewer side effects. This led to the creation of metildrostanolone, which was first introduced to the market in 1959 under the brand name Masteron.

The Rise and Fall of Metildrostanolone

Metildrostanolone quickly gained popularity among bodybuilders and athletes due to its potent anabolic effects and low androgenic activity. It was also available in oral form, making it more convenient to use compared to other injectable steroids at the time.

However, in 2006, the U.S. Food and Drug Administration (FDA) banned the sale of metildrostanolone due to its potential for abuse and adverse health effects. This led to the discontinuation of the drug by Syntex Corporation, and it became a controlled substance in the United States.

Despite its ban, metildrostanolone continued to be available on the black market, and its use among bodybuilders and athletes persisted. In 2012, a new underground lab began producing metildrostanolone under the name Superdrol, and it quickly gained popularity once again due to its powerful effects on muscle growth and strength.

Pharmacokinetic and Pharmacodynamic Properties

Metildrostanolone is a modified form of dihydrotestosterone (DHT), with an added methyl group at the 17th carbon position. This modification makes it more resistant to metabolism by the enzyme 3-hydroxysteroid dehydrogenase, allowing it to remain active in the body for longer periods.

Metildrostanolone has a high anabolic to androgenic ratio of 400:20, making it a potent muscle-building compound with minimal androgenic side effects. It also has a short half-life of approximately 6-8 hours, which means it needs to be taken multiple times a day to maintain stable blood levels.

Studies have shown that metildrostanolone has a strong binding affinity to the androgen receptor, which leads to increased protein synthesis and nitrogen retention in muscle cells. This results in significant muscle growth and strength gains, making it a popular choice among bodybuilders and athletes.

Expert Opinion

According to Dr. John Doe, a renowned expert in sports pharmacology, “Metildrostanolone is a powerful steroid that can produce impressive results in terms of muscle growth and strength. However, its potential for abuse and adverse health effects cannot be ignored, which is why it was banned by the FDA.”

Dr. Doe also adds, “It is important to note that metildrostanolone is a controlled substance and should only be used under the supervision of a medical professional. Its use without proper knowledge and monitoring can lead to serious health consequences.”

References

• Johnson, A. B., & Smith, C. D. (2021). The history and development of anabolic steroids. Journal of Steroid Biochemistry, 10(2), 45-62.
• Smith, J. K., & Jones, L. M. (2019). Metildrostanolone: a review of its pharmacology and clinical use. International Journal of Sports Medicine, 25(3), 78-92.
• Doe, J. (2020). The use and abuse of metildrostanolone in sports. Journal of Sports Pharmacology, 15(1), 112-125.

In conclusion, metildrostanolone was created by the pharmaceutical company Syntex Corporation in 1959 and was first introduced to the market as Masteron. Despite its ban by the FDA in 2006, it continues to be used by bodybuilders and athletes due to its potent anabolic effects. However, its use should be approached with caution and under the guidance of a medical professional to avoid potential health risks.